Tag: Prescription Drugs
Considerable Increase Seen in List, Net Prices of Branded Drugs
From 2007 to 2018, list prices increased 159 percent, while net prices increased by 60 percent
Molecularly Matched Therapy Promising in Pancreatic Cancer
Overall survival significantly longer for patients with actionable molecular alterations receiving matched tx
Recommendations Provided for Treatment of Ulcerative Colitis
Infliximab, adalimumab, golimumab, vedolizumab, tofacitinib, ustekinumab recommended over no tx
Short-Term Medications May Cut Risk for ‘Broken Heart’ Syndrome
Combination of low-dose β-blocker and aspirin may reduce heightened CV risk in early bereavement
Evidence Lacking for Pharmacologic Therapy for Cannabis Use Disorder
Several drug classes including cannabinoids, SSRIs seem to be ineffective for cannabis use disorder
Varenicline Seems Safe for Adults Without Depression
Risk for CV, neuropsychiatric hospitalizations lower for varenicline versus nicotine replacement therapy
Assisting Medication Continuity Cuts Readmissions for Seniors
Interventions that bridge care transitions most likely to impact medication continuity in older adults
Gefapixant Promising for Relief of Unexplained Chronic Cough
Cough frequency significantly reduced after 12 weeks of gefapixant 50 mg versus placebo in phase 2b study
First U.S. Trial of Possible Coronavirus Treatment Begins
University of Nebraska Medical Center is treating 14 people who were evacuated from cruise ship in Japan
Adding Pembrolizumab May Up Response in Triple-Negative Breast Cancer
Pathological complete response rate higher with pembrolizumab plus neoadjuvant chemotherapy
